APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Crohn’s Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173981560322 December 2025181 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Drug Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Crohn’s Disease Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Crohn’s Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Crohn’s Disease Drug include Janssen Biotech, Takeda Pharmaceuticals, Amgen, AbbVie and Tillotts Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Crohn’s Disease Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crohn’s Disease Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crohn’s Disease Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crohn’s Disease Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Crohn’s Disease Drug Segment by Company

Janssen Biotech

Takeda Pharmaceuticals

Amgen

AbbVie

Tillotts Pharma

Crohn’s Disease Drug Segment by Type

Aminosalicylates (5-ASA)

Antibiotics

Immunomodulators

Corticosteroids

Crohn’s Disease Drug Segment by Application

Pediatric Crohn'S Disease

Maintaining Remission (Prevention Of Flare-Ups)

Achieving Remission (The Absence Of Symptoms)

Crohn’s Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Crohn’s Disease Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Crohn’s Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Crohn’s Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Crohn’s Disease Drug Industry Trends Table 2. Crohn’s Disease Drug Industry Drivers Table 3. Crohn’s Disease Drug Industry Opportunities and Challenges Table 4. Crohn’s Disease Drug Industry Restraints Table 5. Global Crohn’s Disease Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Crohn’s Disease Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Crohn’s Disease Drug Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Crohn’s Disease Drug Sales Market Share by Manufacturers Table 9. Global Crohn’s Disease Drug Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Crohn’s Disease Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Crohn’s Disease Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Crohn’s Disease Drug Manufacturers, Product Type & Application Table 13. Global Crohn’s Disease Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Crohn’s Disease Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Aminosalicylates (5-ASA) Table 17. Major Manufacturers of Antibiotics Table 18. Major Manufacturers of Immunomodulators Table 19. Major Manufacturers of Corticosteroids Table 20. Global Crohn’s Disease Drug Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Crohn’s Disease Drug Sales by Type (2021-2026) & (k tons) Table 22. Global Crohn’s Disease Drug Sales by Type (2027-2032) & (k tons) Table 23. Global Crohn’s Disease Drug Sales Market Share by Type (2021-2026) Table 24. Global Crohn’s Disease Drug Sales Market Share by Type (2027-2032) Table 25. Global Crohn’s Disease Drug Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 26. Global Crohn’s Disease Drug Revenue by Type (2021-2026) & (k tons) Table 27. Global Crohn’s Disease Drug Revenue by Type (2027-2032) & (k tons) Table 28. Global Crohn’s Disease Drug Revenue Market Share by Type (2021-2026) Table 29. Global Crohn’s Disease Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pediatric Crohn'S Disease Table 31. Major Manufacturers of Maintaining Remission (Prevention Of Flare-Ups) Table 32. Major Manufacturers of Achieving Remission (The Absence Of Symptoms) Table 33. Global Crohn’s Disease Drug Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global Crohn’s Disease Drug Sales by Application (2021-2026) & (k tons) Table 35. Global Crohn’s Disease Drug Sales by Application (2027-2032) & (k tons) Table 36. Global Crohn’s Disease Drug Sales Market Share by Application (2021-2026) Table 37. Global Crohn’s Disease Drug Sales Market Share by Application (2027-2032) Table 38. Global Crohn’s Disease Drug Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 39. Global Crohn’s Disease Drug Revenue by Application (2021-2026) & (k tons) Table 40. Global Crohn’s Disease Drug Revenue by Application (2027-2032) & (k tons) Table 41. Global Crohn’s Disease Drug Revenue Market Share by Application (2021-2026) Table 42. Global Crohn’s Disease Drug Revenue Market Share by Application (2027-2032) Table 43. Global Crohn’s Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global Crohn’s Disease Drug Sales by Region (2021-2026) & (k tons) Table 45. Global Crohn’s Disease Drug Sales Market Share by Region (2021-2026) Table 46. Global Crohn’s Disease Drug Sales Forecasted by Region (2027-2032) & (k tons) Table 47. Global Crohn’s Disease Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 49. North America Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 50. North America Crohn’s Disease Drug Sales by Country (2027-2032) & (k tons) Table 51. Europe Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 52. Europe Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 53. Europe Crohn’s Disease Drug Sales by Country (2027-2032) & (k tons) Table 54. Asia Pacific Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 55. Asia Pacific Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 56. Asia Pacific Crohn’s Disease Drug Sales by Country (2027-2032) & (k tons) Table 57. South America, Middle East and Africa Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 58. South America, Middle East and Africa Crohn’s Disease Drug Sales by Country (2021-2026) & (k tons) Table 59. South America, Middle East and Africa Crohn’s Disease Drug Sales by Country (2027-2032) & (k tons) Table 60. Global Crohn’s Disease Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Crohn’s Disease Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Crohn’s Disease Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Crohn’s Disease Drug Revenue Market Share by Region (2021-2026) Table 64. Global Crohn’s Disease Drug Revenue Market Share by Region (2027-2032) Table 65. Janssen Biotech Company Information Table 66. Janssen Biotech Business Overview Table 67. Janssen Biotech Crohn’s Disease Drug Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Janssen Biotech Crohn’s Disease Drug Product Portfolio Table 69. Janssen Biotech Recent Development Table 70. Takeda Pharmaceuticals Company Information Table 71. Takeda Pharmaceuticals Business Overview Table 72. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio Table 74. Takeda Pharmaceuticals Recent Development Table 75. Amgen Company Information Table 76. Amgen Business Overview Table 77. Amgen Crohn’s Disease Drug Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Amgen Crohn’s Disease Drug Product Portfolio Table 79. Amgen Recent Development Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Crohn’s Disease Drug Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. AbbVie Crohn’s Disease Drug Product Portfolio Table 84. AbbVie Recent Development Table 85. Tillotts Pharma Company Information Table 86. Tillotts Pharma Business Overview Table 87. Tillotts Pharma Crohn’s Disease Drug Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Tillotts Pharma Crohn’s Disease Drug Product Portfolio Table 89. Tillotts Pharma Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Crohn’s Disease Drug Distributors List Table 93. Crohn’s Disease Drug Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Crohn’s Disease Drug Product Image Figure 2. Global Crohn’s Disease Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crohn’s Disease Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Crohn’s Disease Drug Sales (2021-2032) & (k tons) Figure 5. Global Crohn’s Disease Drug Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Crohn’s Disease Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Aminosalicylates (5-ASA) Image Figure 9. Antibiotics Image Figure 10. Immunomodulators Image Figure 11. Corticosteroids Image Figure 12. Global Crohn’s Disease Drug Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Crohn’s Disease Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Crohn’s Disease Drug Sales Market Share by Type (2021-2032) Figure 15. Global Crohn’s Disease Drug Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global Crohn’s Disease Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Crohn’s Disease Drug Revenue Market Share by Type (2021-2032) Figure 18. Pediatric Crohn'S Disease Image Figure 19. Maintaining Remission (Prevention Of Flare-Ups) Image Figure 20. Achieving Remission (The Absence Of Symptoms) Image Figure 21. Global Crohn’s Disease Drug Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global Crohn’s Disease Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Crohn’s Disease Drug Sales Market Share by Application (2021-2032) Figure 24. Global Crohn’s Disease Drug Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 25. Global Crohn’s Disease Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Crohn’s Disease Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 28. North America Crohn’s Disease Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Canada Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Mexico Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 33. Europe Crohn’s Disease Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 35. France Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 36. U.K. Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Italy Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Netherlands Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Asia Pacific Crohn’s Disease Drug Sales Market Share by Country (2021-2032) Figure 41. China Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Japan Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 43. South Korea Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 44. Southeast Asia Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 45. India Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 46. Australia Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 48. South America, Middle East and Africa Crohn’s Disease Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 50. South Africa Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Saudi Arabia Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Turkey Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 53. Argentina Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 54. UAE Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Egypt Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Chile Crohn’s Disease Drug Sales and Growth Rate (2021-2032) & (k tons) Figure 57. Global Crohn’s Disease Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Crohn’s Disease Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Crohn’s Disease Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Crohn’s Disease Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Crohn’s Disease Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Crohn’s Disease Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Crohn’s Disease Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Crohn’s Disease Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Aminosalicylates (5-ASA)
  • Antibiotics
  • Immunomodulators
  • Corticosteroids
Applications
  • Pediatric Crohn'S Disease
  • Maintaining Remission (Prevention Of Flare-Ups)
  • Achieving Remission (The Absence Of Symptoms)
Companies covered
  • Janssen Biotech
  • Takeda Pharmaceuticals
  • Amgen
  • AbbVie
  • Tillotts Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Crohn’s Disease Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Crohn’s Disease Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Crohn’s Disease Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Crohn’s Disease Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Crohn’s Disease Drug Market Dynamics
  1. 2.1 Crohn’s Disease Drug Industry Trends
  2. 2.2 Crohn’s Disease Drug Industry Drivers
  3. 2.3 Crohn’s Disease Drug Industry Opportunities and Challenges
  4. 2.4 Crohn’s Disease Drug Industry Restraints
3 Crohn’s Disease Drug Market by Manufacturers
  1. 3.1 Global Crohn’s Disease Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Crohn’s Disease Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Crohn’s Disease Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Crohn’s Disease Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Crohn’s Disease Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Crohn’s Disease Drug Manufacturers, Product Type & Application
  7. 3.7 Global Crohn’s Disease Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Crohn’s Disease Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Crohn’s Disease Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Crohn’s Disease Drug Tier 1, Tier 2, and Tier 3
4 Crohn’s Disease Drug Market by Type
  1. 4.1 Crohn’s Disease Drug Type Introduction
  2. 4.1.1 Aminosalicylates (5-ASA)
  3. 4.1.2 Antibiotics
  4. 4.1.3 Immunomodulators
  5. 4.1.4 Corticosteroids
  6. 4.2 Global Crohn’s Disease Drug Sales by Type
  7. 4.2.1 Global Crohn’s Disease Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Crohn’s Disease Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Crohn’s Disease Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Crohn’s Disease Drug Revenue by Type
  11. 4.3.1 Global Crohn’s Disease Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Crohn’s Disease Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Crohn’s Disease Drug Revenue Market Share by Type (2021-2032)
5 Crohn’s Disease Drug Market by Application
  1. 5.1 Crohn’s Disease Drug Application Introduction
  2. 5.1.1 Pediatric Crohn'S Disease
  3. 5.1.2 Maintaining Remission (Prevention Of Flare-Ups)
  4. 5.1.3 Achieving Remission (The Absence Of Symptoms)
  5. 5.2 Global Crohn’s Disease Drug Sales by Application
  6. 5.2.1 Global Crohn’s Disease Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Crohn’s Disease Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Crohn’s Disease Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Crohn’s Disease Drug Revenue by Application
  10. 5.3.1 Global Crohn’s Disease Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Crohn’s Disease Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Crohn’s Disease Drug Revenue Market Share by Application (2021-2032)
6 Global Crohn’s Disease Drug Sales by Region
  1. 6.1 Global Crohn’s Disease Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crohn’s Disease Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Crohn’s Disease Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Crohn’s Disease Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Crohn’s Disease Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Crohn’s Disease Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Crohn’s Disease Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Crohn’s Disease Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Crohn’s Disease Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Crohn’s Disease Drug Revenue by Region
  1. 7.1 Global Crohn’s Disease Drug Revenue by Region
  2. 7.1.1 Global Crohn’s Disease Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Crohn’s Disease Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Crohn’s Disease Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Crohn’s Disease Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Crohn’s Disease Drug Revenue (2021-2032)
  8. 7.2.2 North America Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Crohn’s Disease Drug Revenue (2021-2032)
  11. 7.3.2 Europe Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Crohn’s Disease Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Crohn’s Disease Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Crohn’s Disease Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Biotech
  2. 8.1.1 Janssen Biotech Company Information
  3. 8.1.2 Janssen Biotech Business Overview
  4. 8.1.3 Janssen Biotech Crohn’s Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio
  6. 8.1.5 Janssen Biotech Recent Developments
  7. 8.2 Takeda Pharmaceuticals
  8. 8.2.1 Takeda Pharmaceuticals Company Information
  9. 8.2.2 Takeda Pharmaceuticals Business Overview
  10. 8.2.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio
  12. 8.2.5 Takeda Pharmaceuticals Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Crohn’s Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Crohn’s Disease Drug Product Portfolio
  18. 8.3.5 Amgen Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Crohn’s Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Crohn’s Disease Drug Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Tillotts Pharma
  26. 8.5.1 Tillotts Pharma Company Information
  27. 8.5.2 Tillotts Pharma Business Overview
  28. 8.5.3 Tillotts Pharma Crohn’s Disease Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio
  30. 8.5.5 Tillotts Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Crohn’s Disease Drug Value Chain Analysis
  2. 9.1.1 Crohn’s Disease Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Crohn’s Disease Drug Production Mode & Process
  6. 9.2 Crohn’s Disease Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Crohn’s Disease Drug Distributors
  9. 9.2.3 Crohn’s Disease Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst